Legacy Education (LGCY) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
6 Aug, 2026Company overview and market positioning
Operates six nationally accredited campuses in California, focusing on affordable, career-oriented programs in allied healthcare, veterinary, and business fields.
Achieved 32% year-over-year revenue growth to $77.9M LTM and 9% student enrollment growth to 3,550 as of March 31, 2026.
Maintains high student outcomes: 79% graduation rate, 75% placement rate, and 82% NCLEX pass rate.
Programs are designed for high ROI, shorter durations, and strong alignment with employer needs.
Strategic focus on organic growth, new program development, and accretive acquisitions.
Financial performance and key metrics
LTM net income reached $8.5M and adjusted EBITDA was $12.9M, with net income margins at 11% and EBITDA margins at 15%.
Ended Q3 2026 with $21.7M in cash, $30.9M in working capital, and minimal debt ($0.6M).
Student acquisition cost is $1.6K, generating over 14x annual revenue per student ($22.9K).
Market capitalization stands at $140.6M with 14.0M diluted shares outstanding.
Consistent positive cash flow from operations supports ongoing growth and M&A activities.
Growth strategy and expansion
Organic growth driven by cross-program integration, new program launches, and expanding academic portfolio.
Recent acquisitions (Central Coast, Integrity College, Contra Costa) contributed to 37% of current enrollment.
New programs in healthcare, veterinary, and dental fields, with continuous improvement in pass rates and re-enrollment opportunities.
Hybrid and interactive distance learning models implemented to increase flexibility and scalability.
Active pipeline for further M&A, focusing on accretive, capital-efficient transactions.
Latest events from Legacy Education
- Q3 2026 revenue up 15% and net income up 7.5%, driven by enrollment and new programs.LGCY
Q3 2026 - Achieved 42% revenue growth and 17% enrollment growth, with strong student outcomes and robust liquidity.LGCY
Investor presentation - Achieved 40% revenue growth and 38% enrollment increase, driven by healthcare-focused programs and acquisitions.LGCY
Investor presentation - Q2 revenue up 40.7% and net income up 46%, driven by enrollment and acquisition growth.LGCY
Q2 2026 - Virtual meeting to elect six directors, ratify auditor, and review governance and compensation.LGCY
Proxy Filing - Annual proxy details voting items and confirms standard shareholder rights.LGCY
Proxy Filing - Revenue up 35%, net income doubled, and expansion fueled by IPO and $8M acquisition.LGCY
Q1 2025 - Q2 FY2025 revenue up 29.2% with record enrollment and expanded healthcare offerings.LGCY
Q2 2025 - Q3 revenue rose 50.7% and enrollment 49.8%, driven by CCMCC acquisition and strong demand.LGCY
Q3 2025